Global Biologics and Biosimilars Market Professional Survey Report 2016
- QYR645935
- 110 Pages
- August 2016
- Pharmaceuticals
Production, means the output of Biologics and Biosimilars
Revenue, means the sales value of Biologics and Biosimilars
This report studies Biologics and Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun high tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
By types, the market can be split into
Classification by Technology
Classification by Types
Classification by Use
Classification by Services
By Application, the market can be split into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Global Biologics and Biosimilars Market Professional Survey Report 2016
1 Industry Overview of Biologics and Biosimilars
1.1 Definition and Specifications of Biologics and Biosimilars
1.1.1 Definition of Biologics and Biosimilars
1.1.2 Specifications of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.2.1 Classification by Technology
1.2.2 Classification by Types
1.2.3 Classification by Use
1.2.4 Classification by Services
1.3 Applications of Biologics and Biosimilars
1.3.1 Tumor
1.3.2 Diabetes
1.3.3 Cardiovascular
1.3.4 Hemophilia
1.3.5 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
2.3 Manufacturing Process Analysis of Biologics and Biosimilars
2.4 Industry Chain Structure of Biologics and Biosimilars
3 Technical Data and Manufacturing Plants Analysis of Biologics and Biosimilars
3.1 Capacity and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2015
4 Global Biologics and Biosimilars Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Biologics and Biosimilars Capacity and Growth Rate Analysis
4.2.2 2015 Biologics and Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Biologics and Biosimilars Sales and Growth Rate Analysis
4.3.2 2015 Biologics and Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Biologics and Biosimilars Sales Price
4.4.2 2015 Biologics and Biosimilars Sales Price Analysis (Company Segment)
5 Biologics and Biosimilars Regional Market Analysis
5.1 North America Biologics and Biosimilars Market Analysis
5.1.1 North America Biologics and Biosimilars Market Overview
5.1.2 North America 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.1.4 North America 2015 Biologics and Biosimilars Market Share Analysis
5.2 China Biologics and Biosimilars Market Analysis
5.2.1 China Biologics and Biosimilars Market Overview
5.2.2 China 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.2.4 China 2015 Biologics and Biosimilars Market Share Analysis
5.3 Europe Biologics and Biosimilars Market Analysis
5.3.1 Europe Biologics and Biosimilars Market Overview
5.3.2 Europe 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.3.4 Europe 2015 Biologics and Biosimilars Market Share Analysis
5.4 Southeast Asia Biologics and Biosimilars Market Analysis
5.4.1 Southeast Asia Biologics and Biosimilars Market Overview
5.4.2 Southeast Asia 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.4.4 Southeast Asia 2015 Biologics and Biosimilars Market Share Analysis
5.5 Japan Biologics and Biosimilars Market Analysis
5.5.1 Japan Biologics and Biosimilars Market Overview
5.5.2 Japan 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.5.4 Japan 2015 Biologics and Biosimilars Market Share Analysis
5.6 India Biologics and Biosimilars Market Analysis
5.6.1 India Biologics and Biosimilars Market Overview
5.6.2 India 2011-2016E Biologics and Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Biologics and Biosimilars Sales Price Analysis
5.6.4 India 2015 Biologics and Biosimilars Market Share Analysis
6 Global 2011-2016E Biologics and Biosimilars Segment Market Analysis (by Type)
6.1 Global 2011-2016E Biologics and Biosimilars Sales by Type
6.2 Different Types of Biologics and Biosimilars Product Interview Price Analysis
6.3 Different Types of Biologics and Biosimilars Product Driving Factors Analysis
6.3.1 Classification by Technology of Biologics and Biosimilars Growth Driving Factor Analysis
6.3.2 Classification by Types of Biologics and Biosimilars Growth Driving Factor Analysis
6.3.3 Classification by Use of Biologics and Biosimilars Growth Driving Factor Analysis
6.3.4 Classification by Services of Biologics and Biosimilars Growth Driving Factor Analysis
7 Global 2011-2016E Biologics and Biosimilars Segment Market Analysis (by Application)
7.1 Global 2011-2016E Biologics and Biosimilars Consumption by Application
7.2 Different Application of Biologics and Biosimilars Product Interview Price Analysis
7.3 Different Application of Biologics and Biosimilars Product Driving Factors Analysis
7.3.1 Tumor of Biologics and Biosimilars Growth Driving Factor Analysis
7.3.2 Diabetes of Biologics and Biosimilars Growth Driving Factor Analysis
7.3.3 Cardiovascular of Biologics and Biosimilars Growth Driving Factor Analysis
7.3.4 Hemophilia of Biologics and Biosimilars Growth Driving Factor Analysis
7.3.5 Other of Biologics and Biosimilars Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Biologics and Biosimilars
8.1 Pfizer
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Pfizer 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Pfizer 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.2 Roche
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Roche 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Roche 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.3 Amgen
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Amgen 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Amgen 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.4 AbbVie
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 AbbVie 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 AbbVie 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Sanofi 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.6 Johnson & Johnson
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Johnson & Johnson 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Johnson & Johnson 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.7 Novo Nordisk
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Novo Nordisk 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Novo Nordisk 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.8 Novartis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Novartis 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Novartis 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.9 Merck
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Merck 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Merck 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.10 Lilly
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Lilly 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Lilly 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.11 3sbio
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 3sbio 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 3sbio 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.12 Changchun high tech
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Changchun high tech 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Changchun high tech 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.13 CP Guojian Pharmacy
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 CP Guojian Pharmacy 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 CP Guojian Pharmacy 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.14 Biotech Pharma
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Biotech Pharma 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Biotech Pharma 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.15 Gelgen Biopharma
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Gelgen Biopharma 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Gelgen Biopharma 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.16 Sandoz
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Sandoz 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Sandoz 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.17 Teva
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Teva 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Teva 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.18 Hospira
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Hospira 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Hospira 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.19 Mylan
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.2.1 Type I
8.19.2.2 Type II
8.19.2.3 Type III
8.19.3 Mylan 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Mylan 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.20 3sbio
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.2.1 Type I
8.20.2.2 Type II
8.20.2.3 Type III
8.20.3 3sbio 2015 Biologics and Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 3sbio 2015 Biologics and Biosimilars Business Region Distribution Analysis
8.21 Changchun high tech
8.22 CP Guojian Pharmacy
8.23 Biotech Pharma
8.24 Gelgen Biopharma
9 Development Trend of Analysis of Biologics and Biosimilars Market
9.1 Global Biologics and Biosimilars Market Trend Analysis
9.1.1 Global 2016-2021 Biologics and Biosimilars Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Biologics and Biosimilars Sales Price Forecast
9.2 Biologics and Biosimilars Regional Market Trend
9.2.1 North America 2016-2021 Biologics and Biosimilars Consumption Forecast
9.2.2 China 2016-2021 Biologics and Biosimilars Consumption Forecast
9.2.3 Europe 2016-2021 Biologics and Biosimilars Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Biologics and Biosimilars Consumption Forecast
9.2.5 Japan 2016-2021 Biologics and Biosimilars Consumption Forecast
9.2.6 India 2016-2021 Biologics and Biosimilars Consumption Forecast
9.3 Biologics and Biosimilars Market Trend (Product Type)
9.4 Biologics and Biosimilars Market Trend (Application)
10 Biologics and Biosimilars Marketing Type Analysis
10.1 Biologics and Biosimilars Regional Marketing Type Analysis
10.2 Biologics and Biosimilars International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Biologics and Biosimilars by Regions
10.4 Biologics and Biosimilars Supply Chain Analysis
11 Consumers Analysis of Biologics and Biosimilars
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Biologics and Biosimilars Market Professional Survey Report 2016
Figure Picture of Biologics and Biosimilars
Table Product Specifications of Biologics and Biosimilars
Table Classification of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Figure Classification by Technology Picture
Table Major Manufacturers of Classification by Technology
Figure Classification by Types Picture
Table Major Manufacturers of Classification by Types
Figure Classification by Use Picture
Table Major Manufacturers of Classification by Use
Figure Classification by Services Picture
Table Major Manufacturers of Classification by Services
Table Applications of Biologics and Biosimilars
Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Application in 2015
Figure Tumor Examples
Table Major Consumers of Tumor
Figure Diabetes Examples
Table Major Consumers of Diabetes
Figure Cardiovascular Examples
Table Major Consumers of Cardiovascular
Figure Hemophilia Examples
Table Major Consumers of Hemophilia
Figure Other Examples
Table Major Consumers of Other
Figure Market Share of Biologics and Biosimilars by Regions
Figure North America Biologics and Biosimilars Market Size (2011-2021)
Figure China Biologics and Biosimilars Market Size (2011-2021)
Figure Europe Biologics and Biosimilars Market Size (2011-2021)
Figure Southeast Asia Biologics and Biosimilars Market Size (2011-2021)
Figure Japan Biologics and Biosimilars Market Size (2011-2021)
Figure India Biologics and Biosimilars Market Size (2011-2021)
Table Biologics and Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2015
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Industry Chain Structure of Biologics and Biosimilars
Table Capacity (K Units) and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2015
Table Global Capacity (K Units), Sales (K Units), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
Figure Global 2011-2016E Biologics and Biosimilars Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Biologics and Biosimilars Market Size (Value) and Growth Rate
Table 2011-2016E Global Biologics and Biosimilars Capacity and Growth Rate
Table 2015 Global Biologics and Biosimilars Capacity List (Company Segment)
Table 2011-2016E Global Biologics and Biosimilars Sales and Growth Rate
Table 2015 Global Biologics and Biosimilars Sales List (Company Segment)
Table 2011-2016E Global Biologics and Biosimilars Sales Price
Table 2015 Global Biologics and Biosimilars Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure North America 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure North America 2015 Biologics and Biosimilars Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure China 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure China 2015 Biologics and Biosimilars Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure Europe 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure Europe 2015 Biologics and Biosimilars Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure Southeast Asia 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure Southeast Asia 2015 Biologics and Biosimilars Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure Japan 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure Japan 2015 Biologics and Biosimilars Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
Figure India 2011-2016E Biologics and Biosimilars Sales Price (USD/Unit)
Figure India 2015 Biologics and Biosimilars Sales Market Share
Table Global 2011-2016E Biologics and Biosimilars Sales by Type
Table Different Types Biologics and Biosimilars Product Interview Price
Table Global 2011-2016E Biologics and Biosimilars Sales by Application
Table Different Application Biologics and Biosimilars Product Interview Price
Table Pfizer Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Pfizer Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Biologics and Biosimilars Business Region Distribution
Table Roche Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Roche Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Biologics and Biosimilars Business Region Distribution
Table Amgen Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Amgen Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Amgen 2015 Biologics and Biosimilars Business Region Distribution
Table AbbVie Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 AbbVie Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 AbbVie 2015 Biologics and Biosimilars Business Region Distribution
Table Sanofi Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Sanofi Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Sanofi 2015 Biologics and Biosimilars Business Region Distribution
Table Johnson & Johnson Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Johnson & Johnson Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Johnson & Johnson 2015 Biologics and Biosimilars Business Region Distribution
Table Novo Nordisk Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Novo Nordisk Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Novo Nordisk 2015 Biologics and Biosimilars Business Region Distribution
Table Novartis Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Novartis Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Biologics and Biosimilars Business Region Distribution
Table Merck Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Merck Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Merck 2015 Biologics and Biosimilars Business Region Distribution
Table Lilly Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Lilly Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Lilly 2015 Biologics and Biosimilars Business Region Distribution
Table 3sbio Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 3sbio Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 3sbio 2015 Biologics and Biosimilars Business Region Distribution
Table Changchun high tech Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Changchun high tech Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Changchun high tech 2015 Biologics and Biosimilars Business Region Distribution
Table CP Guojian Pharmacy Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 CP Guojian Pharmacy Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 CP Guojian Pharmacy 2015 Biologics and Biosimilars Business Region Distribution
Table Biotech Pharma Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Biotech Pharma Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Biotech Pharma 2015 Biologics and Biosimilars Business Region Distribution
Table Gelgen Biopharma Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Gelgen Biopharma Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Gelgen Biopharma 2015 Biologics and Biosimilars Business Region Distribution
Table Sandoz Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Sandoz Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Sandoz 2015 Biologics and Biosimilars Business Region Distribution
Table Teva Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Teva Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Teva 2015 Biologics and Biosimilars Business Region Distribution
Table Hospira Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Hospira Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Hospira 2015 Biologics and Biosimilars Business Region Distribution
Table Mylan Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 Mylan Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 Mylan 2015 Biologics and Biosimilars Business Region Distribution
Table 3sbio Information List
Table Type I Biologics and Biosimilars Overview
Table Type II Biologics and Biosimilars Overview
Table Type III Biologics and Biosimilars Overview
Table 2015 3sbio Biologics and Biosimilars Revenue, Sales, Ex-factory Price
Figure 2015 3sbio 2015 Biologics and Biosimilars Business Region Distribution
Table Changchun high tech Information List
Table CP Guojian Pharmacy Information List
Table Biotech Pharma Information List
Table Gelgen Biopharma Information List
Figure Global 2016-2021 Biologics and Biosimilars Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Biologics and Biosimilars Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Biologics and Biosimilars Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Biologics and Biosimilars Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K Units) of Biologics and Biosimilars by Types 2016-2021
Table Global Consumption Volume (K Units) of Biologics and Biosimilars by Applications 2016-2021
Table Traders or Distributors with Contact Information of Biologics and Biosimilars by Regions
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
